G2TT
来源类型Working Paper
规范类型报告
DOI10.3386/w15574
来源IDWorking Paper 15574
An Economic Evaluation of the War on Cancer
Eric C. Sun; Anupam B. Jena; Darius N. Lakdawalla; Carolina M. Reyes; Tomas J. Philipson; Dana P. Goldman
发表日期2009-12-10
出版年2009
语种英语
摘要For decades, the US public and private sectors have committed substantial resources towards cancer research, but the societal payoff has not been well-understood. We quantify the value of recent gains in cancer survival, and analyze the distribution of value among various stakeholders. Between 1988 and 2000, life expectancy for cancer patients increased by roughly four years, and the average willingness-to-pay for these survival gains was roughly $322,000. Improvements in cancer survival during this period created 23 million additional life-years and roughly $1.9 trillion of additional social value, implying that the average life-year was worth approximately $82,000 to its recipient. Health care providers and pharmaceutical companies appropriated 5-19% of this total, with the rest accruing to patients. The share of value flowing to patients has been rising over time. These calculations suggest that from the patient's point of view, the rate of return to R&D investments against cancer has been substantial.
主题Health, Education, and Welfare ; Health ; Education ; Poverty and Wellbeing
URLhttps://www.nber.org/papers/w15574
来源智库National Bureau of Economic Research (United States)
引用统计
资源类型智库出版物
条目标识符http://119.78.100.153/handle/2XGU8XDN/573250
推荐引用方式
GB/T 7714
Eric C. Sun,Anupam B. Jena,Darius N. Lakdawalla,et al. An Economic Evaluation of the War on Cancer. 2009.
条目包含的文件
文件名称/大小 资源类型 版本类型 开放类型 使用许可
w15574.pdf(319KB)智库出版物 限制开放CC BY-NC-SA浏览
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Eric C. Sun]的文章
[Anupam B. Jena]的文章
[Darius N. Lakdawalla]的文章
百度学术
百度学术中相似的文章
[Eric C. Sun]的文章
[Anupam B. Jena]的文章
[Darius N. Lakdawalla]的文章
必应学术
必应学术中相似的文章
[Eric C. Sun]的文章
[Anupam B. Jena]的文章
[Darius N. Lakdawalla]的文章
相关权益政策
暂无数据
收藏/分享
文件名: w15574.pdf
格式: Adobe PDF
此文件暂不支持浏览

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。